|
Status |
Public on Jul 22, 2014 |
Title |
Using a rhabdomyosarcoma patient-derived xenograft to examine precision medicine approaches and model acquired resistance |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by array
|
Summary |
Original patient tumor is directly implanted in mice xenografts. Tumor is propagated to multiple mice for conduct of 6 arm treatment trials and control. Therapies are selected based on T0 and F0 genomic profiles. ICE-T refractory tumor are implanted and additional 6 arm treatment trial and control conducted based on genomic profiles of F2 generation mice to suggested therapies
|
|
|
Overall design |
Original patient tumor expanded in F0 mouse generation to F1 generation for multiple arm therapy trial and then refractory tumors implanted for additional multiple arm therapy trial
|
|
|
Contributor(s) |
Monks NR, Cherba DM |
Citation(s) |
24687871 |
|
Submission date |
Sep 24, 2013 |
Last update date |
Mar 25, 2019 |
Contact name |
David Cherba |
E-mail(s) |
david.cherba@vai.org
|
Phone |
616 234 5382
|
Organization name |
Van Andel Institute
|
Department |
Bioinformatics and Biostatistic Core
|
Street address |
333 Bostwick Ave
|
City |
Grand Rapids |
State/province |
MI |
ZIP/Postal code |
49503 |
Country |
USA |
|
|
Platforms (1) |
GPL570 |
[HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array |
|
Samples (6)
|
GSM1239292 |
Rhabdomyosarcoma original tumorgraft F0 |
GSM1239293 |
Rhabdomyosarcoma ICE-T treated tumorgraft F2 #1 |
GSM1239294 |
Rhabdomyosarcoma ICE-T treated tumorgraft F2 #2 |
GSM1239295 |
Rhabdomyosarcoma ICE-T treated tumorgraft F2 #3 Replicate |
GSM1239296 |
Rhabdomyosarcoma ICE-T treated tumorgraft F2 #3 |
GSM1239297 |
Rhabdomyosarcoma original patient tumor T0 |
|
Relations |
BioProject |
PRJNA221341 |